<DOC>
	<DOCNO>NCT00258804</DOCNO>
	<brief_summary>Primary Objectives : - To compare number hypoglycaemic event ( severe , symptomatic , asymptomatic , nocturnal ) patient type 2 diabetes treat insulin glargine ( Lantus® ) glimepiride ( Amaryl® ) , , period fast Ramadan . Secondary Objectives : - To assess glycaemic control , Ramadan term HbA1c , FBG , 8-point blood glucose profile ( FBG 8-point blood glucose profile collect blood glucose monitor monthly patient diary ) . - To assess relationship hypoglycaemia event Ramadan blood glucose control prior Ramadan . - To assess patient satisfaction - To document adverse event ( serious adverse event , non serious adverse event ) throughout study ( event collect monthly patient diary ) .</brief_summary>
	<brief_title>Insulin Glargine During After Period Fasting Ramadan</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>The following information clinical trial provide information purpose allow patient physician initial discussion trial . This information intend complete information trial , contain consideration may relevant potential participation trial , replace advice personal physician health professional . Main criterion list hereafter : Patients Type 2 Diabetes mellitus ( without history ketoacidosis ) ; BMI &gt; 25 &lt; 40 kg/m2 ; Willingness participate fast Ramadan ; Patients either : Insulin naïve patient Patients already receive insulin Pregnancy ( determined pregnancy blood test inclusion visit ) Breast feed Women childbearing potential adequate contraceptive protection Need treatment study period medication may interfere study protocol Treatment investigational drug ( trial ) last 3 month entry study History drug alcohol abuse Severe unbalance diabetic retinopathy Clinically relevant cardiovascular , gastrointestinal , hepatic , renal , neurological , endocrine , hematological major systemic disease may interfere study protocol complicate interpretation study result Night shift worker</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2011</verification_date>
</DOC>